16 October 2023
Ceasing to be a substantial holder
16 October 2023
DEP HER2-zirconium poster presentation at the AACR-NCI-EORTC conference
16 October 2023
DEP® irinotecan IO/PARP combination data presented at AACR
16 October 2023
DEP irinotecan clinical data presented at AACR meeting
16 October 2023
DEP theranostic presented at international oncology meeting
9 October 2023
Appendix 2A
6 October 2023
Appendix 3Y
6 October 2023
Appendix 3H
2 October 2023
AGM 2023
29 September 2023
Ceasing to be a substantial holder
27 September 2023
DEP® irinotecan combination data presentation
27 September 2023
DEP® irinotecan combination data to be presented at international oncology conference
25 September 2023
VIRALEZE™ UK COVID-19 Clinical Study Completes Recruitment
20 September 2023
Change in substantial holding
13 September 2023
Positive DEP® irinotecan clinical results to be presented at international oncology conference
12 September 2023
Change in substantial holding
28 August 2023
Change of Company Secretary
24 August 2023
Appendix 4G – Corporate Governance Statement
24 August 2023
Starpharma annual report and full-year financial results
17 August 2023
Change in substantial holding

Investor Relations

For general questions about Starpharma Holdings Limited, please contact us at:

T: +61 3 8532 2700
E: investor.relations@starpharma.com


This website is intended for people seeking information about Starpharma for investment and business purposes. This website contains information about products that may not be available, or approved, in all countries, or may be available under different trademarks, or for different indications. Individuals seeking information about a Starpharma product should visit the relevant product website in their country of residence or consult a healthcare provider. Nothing contained on this site should be considered a solicitation, promotion, or advertisement for any product, including those under development. Any information on this site is not intended to provide medical advice nor should be used as a substitute for the advice provided by a doctor or other healthcare provider.